Suraksha Diagnostic Limited — Updates, 28-05-2025: Press Release

Suraksha Diagnostic Limited has announced a board meeting on the financial results for the quarter and half-year. FY25 total income rose 15.2% to ₹256 Cr, with EBITDA up 15.6% at ₹85 Cr and margins steady around 34%. PAT jumped 34% to ₹31 Cr, aided by improved operating leverage despite challenges like doctors' strikes. The company expanded by 7 centers and acquired a 63% stake in Fetomat Wellness, entering genomic medicine and prenatal diagnostics. FY26 plans target 15-18 new centers, margin improvement, and stronger profitability.